data_1n9j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n9j _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.41 107.17 41.49 Favored Pre-proline 0 CA--C 1.562 1.428 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.97 131.4 7.93 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.46 2.106 . . . . 0.0 111.005 175.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.16 75.59 1.27 Allowed Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.89 133.1 6.45 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 141.27 58.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.197 0.998 . . . . 0.0 111.344 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -87.7 -171.8 3.59 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.642 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.31 143.3 57.92 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 122.466 1.127 . . . . 0.0 111.58 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -86.52 108.95 18.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.849 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' GLN . 3.2 mmtt -91.21 130.29 40.48 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 115.146 -2.359 . . . . 0.0 107.665 177.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.47 9.19 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 N-CA-C 119.726 2.933 . . . . 0.0 119.726 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 148.15 135.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 107.287 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.58 166.41 28.83 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.56 -1.655 . . . . 0.0 107.789 175.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -58.72 -38.62 88.09 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 122.167 1.911 . . . . 0.0 115.377 167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -40.77 95.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.0 mm -66.99 -45.14 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 C-N-CA 124.762 1.225 . . . . 0.0 113.874 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -33.65 71.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 166.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.03 -36.85 83.0 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 166.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.427 HG13 ' CD1' ' B' ' 55' ' ' ILE . 30.0 mm -60.89 -56.67 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.643 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' CB ' HG23 ' B' ' 57' ' ' VAL . 4.9 p -49.27 -42.66 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 170.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -62.29 -37.92 87.39 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -31.95 66.8 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 166.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 m -91.52 -22.22 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -42.97 24.91 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 114.35 -2.738 . . . . 0.0 116.926 170.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.61 -41.86 5.66 Favored 'Trans proline' 0 C--N 1.386 2.523 0 CA-C-N 125.163 2.88 . . . . 0.0 114.031 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -71.23 -45.49 63.15 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.67 1.588 . . . . 0.0 113.789 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 mt -57.52 -39.85 77.47 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 116.417 -1.754 . . . . 0.0 114.047 165.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -63.23 -44.28 95.7 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.389 1.904 . . . . 0.0 115.68 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -62.65 -46.45 88.13 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 168.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -35.69 77.45 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.4 t -78.99 -19.19 52.21 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 174.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.0 t30 58.9 33.23 22.91 Favored 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -157.2 154.38 29.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.475 1.607 . . . . 0.0 107.203 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 127.57 44.71 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.293 -1.776 . . . . 0.0 108.367 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -82.97 145.11 29.53 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.831 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.67 -111.71 0.04 OUTLIER Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.259 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -100.32 127.12 46.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.88 115.48 28.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.16 132.25 44.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.09 137.61 55.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 123.571 1.653 . . . . 0.0 111.21 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' B' ' 58' ' ' ARG . 3.4 t -131.83 -141.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -110.5 124.51 51.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 119.944 -1.722 . . . . 0.0 114.822 -151.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -120.64 155.95 32.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.985 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -128.11 172.77 10.67 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 112.713 -2.039 . . . . 0.0 106.915 173.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 p -142.7 127.51 18.22 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.099 -1.0 . . . . 0.0 109.849 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -113.14 132.92 55.27 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -109.24 124.35 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 112.853 -1.976 . . . . 0.0 107.085 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.7 t -89.82 144.55 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.74 148.0 45.19 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.021 1.391 . . . . 0.0 112.017 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.2 18.82 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.722 165.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -128.79 114.59 16.75 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 123.285 1.517 . . . . 0.0 109.408 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.4 146.46 33.03 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 112.268 -2.242 . . . . 0.0 105.085 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -129.66 134.75 47.85 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.002 -1.686 . . . . 0.0 107.538 -170.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.445 ' CD1' ' HG3' ' B' ' 46' ' ' GLN . 7.3 m-85 -128.75 130.32 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.0 mt -129.34 142.91 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 121.697 0.761 . . . . 0.0 109.007 -173.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.718 ' HD3' ' HE2' ' A' ' 66' ' ' HIS . 2.5 ttpt -106.83 142.28 36.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 124.332 2.015 . . . . 0.0 105.753 165.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.77 145.83 19.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 111.354 -2.657 . . . . 0.0 105.807 -171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -104.56 102.92 12.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 164.44 11.3 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 111.365 -2.652 . . . . 0.0 109.234 134.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.58 170.74 0.13 Allowed Glycine 0 CA--C 1.554 2.525 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -34.07 -29.33 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 120.816 3.636 . . . . 0.0 120.816 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.3 -36.89 29.26 Favored 'General case' 0 CA--C 1.576 1.97 0 C-N-CA 125.434 1.494 . . . . 0.0 113.605 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.15 157.79 35.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.357 1.551 . . . . 0.0 109.596 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -157.71 127.32 6.0 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.468 ' SD ' HD13 ' B' ' 27' ' ' LEU . 2.8 mtm -109.35 149.95 28.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.716 1.722 . . . . 0.0 111.634 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.718 ' HE2' ' HD3' ' A' ' 56' ' ' LYS . 5.7 m170 -106.23 154.11 21.19 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 112.34 -2.209 . . . . 0.0 108.536 163.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.92 150.16 48.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.453 -2.158 . . . . 0.0 109.206 -177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.52 117.63 10.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.888 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 77.8 t -128.73 124.13 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -83.29 135.49 34.73 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.218 167.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.08 143.83 49.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.234 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.9 t -109.56 -80.54 0.58 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.119 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 124.16 68.76 Favored Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 123.482 0.713 . . . . 0.0 110.081 -174.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.05 164.96 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 122.796 2.331 . . . . 0.0 112.629 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.82 -8.73 68.23 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -124.86 105.96 9.65 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -57.54 -45.69 84.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 116.764 -1.588 . . . . 0.0 112.429 166.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -20.97 6.69 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -13.25 61.84 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.8 120.99 10.0 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 109.173 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -125.0 131.17 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.4 tp -64.33 112.61 3.15 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.306 165.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.4 p -111.14 -27.96 8.5 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.79 167.4 26.72 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -172.84 126.89 0.48 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.536 -2.155 . . . . 0.0 105.592 -170.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.411 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -106.8 161.74 14.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 124.057 1.884 . . . . 0.0 108.45 177.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -168.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 112.538 -2.119 . . . . 0.0 111.87 -166.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -38.25 4.15 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 122.719 4.34 . . . . 0.0 122.719 163.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 140.49 58.29 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 168.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -61.3 170.15 1.87 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.039 -168.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -54.68 -28.67 49.18 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 163.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.06 42.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 166.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.08 112.33 1.18 Allowed 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.993 0.815 . . . . 0.0 110.313 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -80.62 134.2 35.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.11 102.09 10.04 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -139.85 80.94 1.8 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -164.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 40.19 31.41 0.33 Allowed Glycine 0 CA--C 1.569 3.437 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER . . . . . 0 CA--C 1.568 1.657 0 C-N-CA 126.62 1.968 . . . . 0.0 109.504 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.9 136.17 22.39 Favored Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 124.459 1.104 . . . . 0.0 108.036 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.47 158.01 57.63 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 121.787 1.658 . . . . 0.0 111.676 165.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.03 175.08 2.28 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-O 122.566 1.092 . . . . 0.0 113.517 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 154.68 7.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 123.912 1.84 . . . . 0.0 109.223 -165.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.76 146.46 51.45 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 111.992 -2.104 . . . . 0.0 112.078 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -174.62 0.34 Allowed 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.824 0.821 . . . . 0.0 111.533 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.76 140.83 58.18 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 122.616 1.198 . . . . 0.0 112.27 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' B' ' 43' ' ' TYR . . . -84.63 107.72 16.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 112.636 -2.074 . . . . 0.0 110.759 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' B' ' 42' ' ' GLN . 20.8 mmtp -92.87 121.97 64.79 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-O 115.518 -2.182 . . . . 0.0 109.353 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.06 6.37 0.5 Allowed 'Trans proline' 0 C--N 1.362 1.271 0 N-CA-C 121.1 3.461 . . . . 0.0 121.1 -170.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 150.26 74.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.255 1.822 . . . . 0.0 106.745 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' THR . . . . . 0.518 ' H ' ' CD1' ' B' ' 16' ' ' ILE . 0.1 OUTLIER -68.27 159.03 82.61 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -58.01 -36.03 98.33 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.684 1.589 . . . . 0.0 115.346 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -56.92 -49.44 75.61 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.518 ' CD1' ' H ' ' B' ' 13' ' ' THR . 28.4 mt -49.82 -50.78 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 120.763 1.619 . . . . 0.0 113.316 173.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -40.85 95.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.666 0.604 . . . . 0.0 112.455 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.48 -39.31 90.48 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 169.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . . . . . . . . . 16.7 mt -63.58 -58.65 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 117.432 -1.27 . . . . 0.0 109.438 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 p -53.16 -41.36 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 171.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.28 -52.17 66.71 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 119.928 1.24 . . . . 0.0 112.398 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -61.62 -30.84 70.96 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.7 t -93.57 -13.46 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.05 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -49.94 -55.32 24.8 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 122.091 2.223 . . . . 0.0 113.825 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.16 -40.08 44.24 Favored 'Trans proline' 0 C--N 1.381 2.26 0 CA-C-N 123.737 2.37 . . . . 0.0 115.522 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.53 -38.68 81.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.959 1.303 . . . . 0.0 114.444 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.22 -47.84 83.84 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.198 0.999 . . . . 0.0 112.891 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.73 -37.5 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -64.2 -44.45 91.92 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -41.84 70.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -83.4 -8.91 59.31 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.709 -1.139 . . . . 0.0 113.952 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.3 t30 53.7 21.0 2.43 Favored 'General case' 0 CA--C 1.591 2.526 0 CA-C-N 121.554 1.979 . . . . 0.0 115.861 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.26 149.95 38.38 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.431 1.11 . . . . 0.0 108.459 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 126.35 49.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.52 147.27 31.98 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.87 -114.53 0.01 OUTLIER Glycine 0 CA--C 1.544 1.888 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.949 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -103.81 127.59 51.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 29.4 mt -101.87 115.34 30.31 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.61 145.78 38.58 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 140.19 45.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.443 1.592 . . . . 0.0 113.804 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.405 ' CG1' ' H ' ' B' ' 42' ' ' GLN . 10.4 t -138.56 -146.65 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 111.017 -2.81 . . . . 0.0 104.432 173.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' B' ' 10' ' ' LYS 0.286 12.8 pt20 -89.73 123.59 33.87 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.106 -1.621 . . . . 0.0 111.425 -162.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -107.79 156.73 18.81 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 110.242 174.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -127.72 154.97 44.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 123.586 1.66 . . . . 0.0 108.491 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.11 161.5 14.1 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.16 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLN . . . . . 0.445 ' HG3' ' CD1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -135.3 135.08 40.53 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.96 118.43 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -84.74 151.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.396 162.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.0 142.58 51.51 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 122.252 1.025 . . . . 0.0 110.993 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.08 151.5 16.86 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 166.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -124.09 110.94 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.476 1.138 . . . . 0.0 108.532 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.2 156.39 16.87 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 161.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -129.3 145.31 51.39 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -125.54 117.8 24.39 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.427 ' CD1' HG13 ' A' ' 19' ' ' ILE . 88.0 mt -121.82 146.51 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 120.782 1.628 . . . . 0.0 110.251 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -114.33 143.82 44.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 123.723 1.725 . . . . 0.0 109.019 158.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' ' 20' ' ' VAL . 12.5 p -162.6 117.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.435 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ARG . . . . . 0.454 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 3.7 ptt180 -81.14 99.83 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 120.83 -1.169 . . . . 0.0 112.317 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.54 87.98 2.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.249 -2.251 . . . . 0.0 105.351 166.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . -132.81 168.62 22.79 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 160.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.81 -56.72 18.3 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.86 -0.788 . . . . 0.0 111.416 161.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -116.75 18.02 15.0 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -122.32 174.18 7.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.785 1.279 . . . . 0.0 111.516 -163.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' B' ' 58' ' ' ARG . 2.6 m-85 -125.18 133.56 52.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' MET . . . . . 0.442 ' H ' ' HA ' ' B' ' 58' ' ' ARG . 1.2 ttm -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.89 -1.131 . . . . 0.0 107.978 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' HIS . . . . . 0.426 ' HD1' ' HB3' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -136.46 114.75 11.66 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 120.238 -1.539 . . . . 0.0 111.601 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.428 HD21 ' SD ' ' B' ' 65' ' ' MET . 0.6 OUTLIER -129.45 141.86 50.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.71 140.23 29.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.681 169.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -126.6 120.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -82.72 133.71 35.15 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.775 0.798 . . . . 0.0 111.146 167.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -123.42 147.28 47.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.517 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -86.9 -91.61 0.1 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.51 138.4 22.36 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.921 0.888 . . . . 0.0 110.59 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.46 163.77 35.42 Favored 'Trans proline' 0 CA--C 1.562 1.905 0 C-N-CA 122.755 2.303 . . . . 0.0 112.743 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.98 11.17 85.65 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.993 1.957 . . . . 0.0 117.993 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -129.74 112.45 13.65 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -63.5 -41.28 98.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.41 -20.8 66.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.44 -22.6 66.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.402 HD23 ' CD1' ' A' ' 19' ' ' ILE . 7.5 mp -80.67 111.13 16.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 98.9 t -122.24 123.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -173.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 15.8 tp -70.89 113.14 7.65 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.079 166.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.43 -20.19 13.8 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.37 141.12 7.95 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -145.13 155.59 43.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.526 1.631 . . . . 0.0 110.663 -175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -128.48 156.05 43.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 105.863 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.65 -169.71 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 112.449 -2.16 . . . . 0.0 109.003 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -24.35 -8.86 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.832 1 N-CA-C 124.872 5.138 . . . . 0.0 124.872 165.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 146.55 50.0 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 166.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -77.79 -176.86 4.6 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.271 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.83 -19.51 4.49 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 119.384 3.105 . . . . 0.0 119.384 166.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.97 -31.55 63.09 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ASP . . . . . 0.426 ' HB3' ' HD1' ' B' ' 66' ' ' HIS . 2.3 t0 -74.71 103.87 5.15 Favored 'General case' 0 C--N 1.361 1.101 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.36 140.56 30.68 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.89 97.09 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.978 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' THR . . . . . . . . . . . . . 1.3 p -127.78 118.87 24.53 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -161.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.19 32.7 5.14 Favored Glycine 0 CA--C 1.562 3.022 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--O 1.242 0.684 1 N-CA-C 99.697 -4.186 . . . . 0.0 99.697 -160.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.41 107.17 41.49 Favored Pre-proline 0 CA--C 1.562 1.428 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.605 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 74.3 Cg_endo -80.97 131.4 7.93 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.46 2.106 . . . . 0.0 111.005 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.16 75.59 1.27 Allowed Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.89 133.1 6.45 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 141.27 58.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.197 0.998 . . . . 0.0 111.344 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -87.7 -171.8 3.59 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.642 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.31 143.3 57.92 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 122.466 1.127 . . . . 0.0 111.58 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.778 ' HB2' ' HD3' ' A' ' 44' ' ' LYS . . . -86.52 108.95 18.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.849 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -91.21 130.29 40.48 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 115.146 -2.359 . . . . 0.0 107.665 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.47 9.19 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 N-CA-C 119.726 2.933 . . . . 0.0 119.726 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 40' ' ' ALA . . . 148.15 135.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 107.287 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.58 166.41 28.83 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.56 -1.655 . . . . 0.0 107.789 175.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -58.72 -38.62 88.09 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 122.167 1.911 . . . . 0.0 115.377 167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -40.77 95.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.703 HG23 HG23 ' B' ' 55' ' ' ILE . 8.0 mm -66.99 -45.14 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 C-N-CA 124.762 1.225 . . . . 0.0 113.874 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HG2' ' H ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -59.55 -33.65 71.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 166.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.03 -36.85 83.0 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 166.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.823 HG21 HD12 ' B' ' 55' ' ' ILE . 30.0 mm -60.89 -56.67 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.643 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 23' ' ' VAL . 4.9 p -49.27 -42.66 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 170.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -62.29 -37.92 87.39 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -31.95 66.8 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 166.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 20' ' ' VAL . 5.8 m -91.52 -22.22 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -42.97 24.91 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 114.35 -2.738 . . . . 0.0 116.926 170.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.61 -41.86 5.66 Favored 'Trans proline' 0 C--N 1.386 2.523 0 CA-C-N 125.163 2.88 . . . . 0.0 114.031 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -71.23 -45.49 63.15 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.67 1.588 . . . . 0.0 113.789 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD13 ' SD ' ' B' ' 65' ' ' MET . 5.5 mt -57.52 -39.85 77.47 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 116.417 -1.754 . . . . 0.0 114.047 165.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.1 mt-10 -63.23 -44.28 95.7 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.389 1.904 . . . . 0.0 115.68 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -62.65 -46.45 88.13 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 168.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -35.69 77.45 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 28' ' ' GLU . 2.4 t -78.99 -19.19 52.21 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.0 t30 58.9 33.23 22.91 Favored 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' N ' HG23 ' A' ' 31' ' ' THR . 29.9 tt0 -157.2 154.38 29.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.475 1.607 . . . . 0.0 107.203 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 127.57 44.71 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.293 -1.776 . . . . 0.0 108.367 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -82.97 145.11 29.53 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.831 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.67 -111.71 0.04 OUTLIER Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.259 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -100.32 127.12 46.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.745 HD22 ' HB1' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -98.88 115.48 28.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 -171.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.16 132.25 44.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' H ' ' HG2' ' A' ' 17' ' ' GLN . . . -57.09 137.61 55.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 123.571 1.653 . . . . 0.0 111.21 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.554 HG23 ' H ' ' B' ' 58' ' ' ARG . 3.4 t -131.83 -141.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.58 ' H ' ' HB3' ' B' ' 56' ' ' LYS . 0.0 OUTLIER -110.5 124.51 51.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 119.944 -1.722 . . . . 0.0 114.822 -151.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' B' ' 55' ' ' ILE . 1.5 p90 -120.64 155.95 32.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.985 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.778 ' HD3' ' HB2' ' A' ' 9' ' ' ALA . 6.4 mtmt -128.11 172.77 10.67 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 112.713 -2.039 . . . . 0.0 106.915 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 p -142.7 127.51 18.22 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.099 -1.0 . . . . 0.0 109.849 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -113.14 132.92 55.27 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -109.24 124.35 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 112.853 -1.976 . . . . 0.0 107.085 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.7 t -89.82 144.55 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 3' ' ' PRO . . . -121.74 148.0 45.19 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.021 1.391 . . . . 0.0 112.017 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.2 18.82 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.722 165.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -128.79 114.59 16.75 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 123.285 1.517 . . . . 0.0 109.408 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.4 146.46 33.03 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 112.268 -2.242 . . . . 0.0 105.085 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -129.66 134.75 47.85 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.002 -1.686 . . . . 0.0 107.538 -170.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.56 ' CD1' ' HG3' ' B' ' 46' ' ' GLN . 7.3 m-85 -128.75 130.32 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.635 HD11 HD13 ' B' ' 19' ' ' ILE . 7.0 mt -129.34 142.91 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 121.697 0.761 . . . . 0.0 109.007 -173.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HD3' ' NE2' ' A' ' 66' ' ' HIS . 2.5 ttpt -106.83 142.28 36.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 124.332 2.015 . . . . 0.0 105.753 165.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -146.77 145.83 19.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 111.354 -2.657 . . . . 0.0 105.807 -171.062 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.402 ' HB3' HG21 ' B' ' 41' ' ' VAL . 29.7 ptt180 -104.56 102.92 12.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 -176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 164.44 11.3 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 111.365 -2.652 . . . . 0.0 109.234 134.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.58 170.74 0.13 Allowed Glycine 0 CA--C 1.554 2.525 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -34.07 -29.33 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 120.816 3.636 . . . . 0.0 120.816 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.3 -36.89 29.26 Favored 'General case' 0 CA--C 1.576 1.97 0 C-N-CA 125.434 1.494 . . . . 0.0 113.605 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.15 157.79 35.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.357 1.551 . . . . 0.0 109.596 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -157.71 127.32 6.0 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.73 ' SD ' HD13 ' B' ' 27' ' ' LEU . 2.8 mtm -109.35 149.95 28.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.716 1.722 . . . . 0.0 111.634 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 86' ' ' GLN . 5.7 m170 -106.23 154.11 21.19 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 112.34 -2.209 . . . . 0.0 108.536 163.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.896 HD21 HG21 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -136.92 150.16 48.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.453 -2.158 . . . . 0.0 109.206 -177.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.52 117.63 10.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.888 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 67' ' ' LEU . 77.8 t -128.73 124.13 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -83.29 135.49 34.73 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.218 167.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.08 143.83 49.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.234 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.9 t -109.56 -80.54 0.58 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.119 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 124.16 68.76 Favored Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 123.482 0.713 . . . . 0.0 110.081 -174.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.05 164.96 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 122.796 2.331 . . . . 0.0 112.629 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.82 -8.73 68.23 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -124.86 105.96 9.65 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.491 ' O ' HD22 ' A' ' 80' ' ' LEU . 14.9 t30 -57.54 -45.69 84.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 116.764 -1.588 . . . . 0.0 112.429 166.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -20.97 6.69 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -13.25 61.84 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 77' ' ' ASN . 0.4 OUTLIER -58.8 120.99 10.0 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 109.173 168.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -125.0 131.17 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.651 HD11 ' HD1' ' A' ' 85' ' ' TYR . 16.4 tp -64.33 112.61 3.15 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.306 165.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.4 p -111.14 -27.96 8.5 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.79 167.4 26.72 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.651 ' HD1' HD11 ' A' ' 82' ' ' LEU . 4.6 p90 -172.84 126.89 0.48 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.536 -2.155 . . . . 0.0 105.592 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -106.8 161.74 14.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 124.057 1.884 . . . . 0.0 108.45 177.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -168.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 112.538 -2.119 . . . . 0.0 111.87 -166.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -38.25 4.15 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 122.719 4.34 . . . . 0.0 122.719 163.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 140.49 58.29 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 168.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -61.3 170.15 1.87 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.039 -168.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.596 ' HD2' HG11 ' B' ' 41' ' ' VAL . 8.6 tttm -54.68 -28.67 49.18 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 163.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.06 42.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 166.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.08 112.33 1.18 Allowed 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.993 0.815 . . . . 0.0 110.313 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 96' ' ' THR . 6.6 tt0 -80.62 134.2 35.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -81.11 102.09 10.04 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 94' ' ' GLU . 1.8 t -139.85 80.94 1.8 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -164.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 40.19 31.41 0.33 Allowed Glycine 0 CA--C 1.569 3.437 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER . . . . . 0 CA--C 1.568 1.657 0 C-N-CA 126.62 1.968 . . . . 0.0 109.504 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.9 136.17 22.39 Favored Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 124.459 1.104 . . . . 0.0 108.036 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.47 158.01 57.63 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 121.787 1.658 . . . . 0.0 111.676 165.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.03 175.08 2.28 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-O 122.566 1.092 . . . . 0.0 113.517 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 154.68 7.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 123.912 1.84 . . . . 0.0 109.223 -165.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.76 146.46 51.45 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 111.992 -2.104 . . . . 0.0 112.078 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -174.62 0.34 Allowed 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.824 0.821 . . . . 0.0 111.533 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.76 140.83 58.18 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 122.616 1.198 . . . . 0.0 112.27 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 43' ' ' TYR . . . -84.63 107.72 16.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 112.636 -2.074 . . . . 0.0 110.759 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 42' ' ' GLN . 20.8 mmtp -92.87 121.97 64.79 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-O 115.518 -2.182 . . . . 0.0 109.353 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.06 6.37 0.5 Allowed 'Trans proline' 0 C--N 1.362 1.271 0 N-CA-C 121.1 3.461 . . . . 0.0 121.1 -170.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 150.26 74.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.255 1.822 . . . . 0.0 106.745 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' THR . . . . . 0.77 ' H ' HD12 ' B' ' 16' ' ' ILE . 0.1 OUTLIER -68.27 159.03 82.61 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' B' ' 13' ' ' THR . 59.5 Cg_endo -58.01 -36.03 98.33 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.684 1.589 . . . . 0.0 115.346 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -56.92 -49.44 75.61 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.77 HD12 ' H ' ' B' ' 13' ' ' THR . 28.4 mt -49.82 -50.78 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 120.763 1.619 . . . . 0.0 113.316 173.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLN . . . . . 0.481 ' CA ' ' HB2' ' B' ' 40' ' ' ALA . 0.4 OUTLIER -64.96 -40.85 95.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.666 0.604 . . . . 0.0 112.455 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.48 -39.31 90.48 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 169.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 55' ' ' ILE . 16.7 mt -63.58 -58.65 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 117.432 -1.27 . . . . 0.0 109.438 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.522 ' CG2' HG11 ' A' ' 57' ' ' VAL . 1.4 p -53.16 -41.36 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 171.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.28 -52.17 66.71 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 119.928 1.24 . . . . 0.0 112.398 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -61.62 -30.84 70.96 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.896 HG21 HD21 ' A' ' 67' ' ' LEU . 13.7 t -93.57 -13.46 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.05 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -49.94 -55.32 24.8 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 122.091 2.223 . . . . 0.0 113.825 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.16 -40.08 44.24 Favored 'Trans proline' 0 C--N 1.381 2.26 0 CA-C-N 123.737 2.37 . . . . 0.0 115.522 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.53 -38.68 81.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.959 1.303 . . . . 0.0 114.444 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.73 HD13 ' SD ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.22 -47.84 83.84 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.198 0.999 . . . . 0.0 112.891 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.73 -37.5 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -64.2 -44.45 91.92 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -41.84 70.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -83.4 -8.91 59.31 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.709 -1.139 . . . . 0.0 113.952 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.3 t30 53.7 21.0 2.43 Favored 'General case' 0 CA--C 1.591 2.526 0 CA-C-N 121.554 1.979 . . . . 0.0 115.861 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.26 149.95 38.38 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.431 1.11 . . . . 0.0 108.459 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 126.35 49.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.52 147.27 31.98 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.87 -114.53 0.01 OUTLIER Glycine 0 CA--C 1.544 1.888 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.949 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -103.81 127.59 51.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.487 HD21 ' HE1' ' A' ' 65' ' ' MET . 29.4 mt -101.87 115.34 30.31 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.61 145.78 38.58 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' CA ' ' B' ' 17' ' ' GLN . . . -56.3 140.19 45.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.443 1.592 . . . . 0.0 113.804 171.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.596 HG11 ' HD2' ' A' ' 91' ' ' LYS . 10.4 t -138.56 -146.65 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 111.017 -2.81 . . . . 0.0 104.432 173.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.511 ' H ' HG12 ' B' ' 41' ' ' VAL 0.286 12.8 pt20 -89.73 123.59 33.87 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.106 -1.621 . . . . 0.0 111.425 -162.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TYR . . . . . 0.685 ' CD1' HD11 ' B' ' 16' ' ' ILE . 0.1 OUTLIER -107.79 156.73 18.81 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 110.242 174.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -127.72 154.97 44.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 123.586 1.66 . . . . 0.0 108.491 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.11 161.5 14.1 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.16 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLN . . . . . 0.56 ' HG3' ' CD1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -135.3 135.08 40.53 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.96 118.43 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -84.74 151.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.396 162.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.0 142.58 51.51 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 122.252 1.025 . . . . 0.0 110.993 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.08 151.5 16.86 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 166.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -124.09 110.94 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.476 1.138 . . . . 0.0 108.532 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.2 156.39 16.87 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 161.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -129.3 145.31 51.39 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' TYR . . . . . 0.435 ' HB3' HD22 ' B' ' 95' ' ' LEU . 15.2 m-85 -125.54 117.8 24.39 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.823 HD12 HG21 ' A' ' 19' ' ' ILE . 88.0 mt -121.82 146.51 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 120.782 1.628 . . . . 0.0 110.251 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 42' ' ' GLN . 15.0 ttpt -114.33 143.82 44.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 123.723 1.725 . . . . 0.0 109.019 158.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' VAL . . . . . 0.6 HG21 HG11 ' A' ' 20' ' ' VAL . 12.5 p -162.6 117.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.435 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ARG . . . . . 0.554 ' H ' HG23 ' A' ' 41' ' ' VAL . 3.7 ptt180 -81.14 99.83 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 120.83 -1.169 . . . . 0.0 112.317 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' A' ' 38' ' ' LEU . . . -122.54 87.98 2.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.249 -2.251 . . . . 0.0 105.351 166.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' B' ' 63' ' ' LYS . . . -132.81 168.62 22.79 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 160.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.81 -56.72 18.3 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.86 -0.788 . . . . 0.0 111.416 161.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -116.75 18.02 15.0 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . 0.418 ' HB2' ' HA3' ' B' ' 60' ' ' GLY . 0.6 OUTLIER -122.32 174.18 7.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.785 1.279 . . . . 0.0 111.516 -163.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' B' ' 58' ' ' ARG . 2.6 m-85 -125.18 133.56 52.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' MET . . . . . 0.546 ' SD ' HD13 ' A' ' 27' ' ' LEU . 1.2 ttm -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.89 -1.131 . . . . 0.0 107.978 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' HIS . . . . . 0.519 ' CD2' HD23 ' B' ' 95' ' ' LEU . 0.0 OUTLIER -136.46 114.75 11.66 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 120.238 -1.539 . . . . 0.0 111.601 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.715 HD11 HG11 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -129.45 141.86 50.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.71 140.23 29.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.681 169.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 19' ' ' ILE . 69.0 t -126.6 120.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -82.72 133.71 35.15 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.775 0.798 . . . . 0.0 111.146 167.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -123.42 147.28 47.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.517 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -86.9 -91.61 0.1 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.51 138.4 22.36 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.921 0.888 . . . . 0.0 110.59 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.46 163.77 35.42 Favored 'Trans proline' 0 CA--C 1.562 1.905 0 C-N-CA 122.755 2.303 . . . . 0.0 112.743 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.98 11.17 85.65 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.993 1.957 . . . . 0.0 117.993 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -129.74 112.45 13.65 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -63.5 -41.28 98.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.41 -20.8 66.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.44 -22.6 66.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 19' ' ' ILE . 7.5 mp -80.67 111.13 16.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.404 ' C ' HG13 ' B' ' 69' ' ' VAL . 98.9 t -122.24 123.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -173.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' B' ' 85' ' ' TYR . 15.8 tp -70.89 113.14 7.65 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.079 166.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.43 -20.19 13.8 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.37 141.12 7.95 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' TYR . . . . . 0.474 ' HB3' HD11 ' B' ' 82' ' ' LEU . 25.1 p90 -145.13 155.59 43.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.526 1.631 . . . . 0.0 110.663 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -128.48 156.05 43.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 105.863 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.65 -169.71 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 112.449 -2.16 . . . . 0.0 109.003 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -24.35 -8.86 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.832 1 N-CA-C 124.872 5.138 . . . . 0.0 124.872 165.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -62.06 146.55 50.0 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 166.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -77.79 -176.86 4.6 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.271 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.83 -19.51 4.49 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 119.384 3.105 . . . . 0.0 119.384 166.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.97 -31.55 63.09 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' B' ' 89' ' ' LYS . 2.3 t0 -74.71 103.87 5.15 Favored 'General case' 0 C--N 1.361 1.101 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' GLU . . . . . 0.422 ' O ' HG23 ' B' ' 96' ' ' THR . 0.0 OUTLIER -85.36 140.56 30.68 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' B' ' 66' ' ' HIS . 0.0 OUTLIER -83.89 97.09 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.978 -177.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 96' ' ' THR . . . . . 0.422 HG23 ' O ' ' B' ' 94' ' ' GLU . 1.3 p -127.78 118.87 24.53 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -161.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.19 32.7 5.14 Favored Glycine 0 CA--C 1.562 3.022 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--O 1.242 0.684 1 N-CA-C 99.697 -4.186 . . . . 0.0 99.697 -160.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttp . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.1 pp -119.41 107.17 41.49 Favored Pre-proline 0 CA--C 1.562 1.428 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -173.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.605 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 74.3 Cg_endo -80.97 131.4 7.93 Favored 'Trans proline' 0 C--N 1.363 1.336 0 C-N-CA 122.46 2.106 . . . . 0.0 111.005 175.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.16 75.59 1.27 Allowed Glycine 0 N--CA 1.477 1.413 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -135.89 133.1 6.45 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 176.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 141.27 58.58 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 122.197 0.998 . . . . 0.0 111.344 175.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.6 m -87.7 -171.8 3.59 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.642 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -63.31 143.3 57.92 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 122.466 1.127 . . . . 0.0 111.58 173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.778 ' HB2' ' HD3' ' A' ' 44' ' ' LYS . . . -86.52 108.95 18.78 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.608 -1.633 . . . . 0.0 109.849 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -91.21 130.29 40.48 Favored Pre-proline 0 N--CA 1.497 1.877 0 CA-C-O 115.146 -2.359 . . . . 0.0 107.665 177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.47 9.19 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.061 0 N-CA-C 119.726 2.933 . . . . 0.0 119.726 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 40' ' ' ALA . . . 148.15 135.72 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.739 1.615 . . . . 0.0 107.287 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.58 166.41 28.83 Favored Pre-proline 0 CA--C 1.573 1.842 0 CA-C-N 113.56 -1.655 . . . . 0.0 107.789 175.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -58.72 -38.62 88.09 Favored 'Trans proline' 0 CA--C 1.567 2.146 0 C-N-CA 122.167 1.911 . . . . 0.0 115.377 167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.47 -40.77 95.75 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 169.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.703 HG23 HG23 ' B' ' 55' ' ' ILE . 8.0 mm -66.99 -45.14 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.328 0 C-N-CA 124.762 1.225 . . . . 0.0 113.874 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.459 ' HG2' ' H ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -59.55 -33.65 71.67 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 166.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -67.03 -36.85 83.0 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 166.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.823 HG21 HD12 ' B' ' 55' ' ' ILE . 30.0 mm -60.89 -56.67 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-O 117.086 -1.435 . . . . 0.0 111.643 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 23' ' ' VAL . 4.9 p -49.27 -42.66 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 170.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -62.29 -37.92 87.39 Favored 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.96 -31.95 66.8 Favored 'General case' 0 CA--C 1.568 1.637 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 166.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.785 HG22 ' HA ' ' A' ' 20' ' ' VAL . 5.8 m -91.52 -22.22 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -172.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.67 -42.97 24.91 Favored Pre-proline 0 CA--C 1.556 1.174 0 CA-C-O 114.35 -2.738 . . . . 0.0 116.926 170.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.61 -41.86 5.66 Favored 'Trans proline' 0 C--N 1.386 2.523 0 CA-C-N 125.163 2.88 . . . . 0.0 114.031 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -71.23 -45.49 63.15 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.67 1.588 . . . . 0.0 113.789 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.546 HD13 ' SD ' ' B' ' 65' ' ' MET . 5.5 mt -57.52 -39.85 77.47 Favored 'General case' 0 CA--C 1.553 1.093 0 CA-C-O 116.417 -1.754 . . . . 0.0 114.047 165.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.422 ' HA ' HG22 ' A' ' 31' ' ' THR . 3.1 mt-10 -63.23 -44.28 95.7 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 121.389 1.904 . . . . 0.0 115.68 177.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -62.65 -46.45 88.13 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 168.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -35.69 77.45 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 116.285 1.957 . . . . 0.0 116.285 176.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 28' ' ' GLU . 2.4 t -78.99 -19.19 52.21 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.0 t30 58.9 33.23 22.91 Favored 'General case' 0 CA--C 1.587 2.385 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' N ' HG23 ' A' ' 31' ' ' THR . 29.9 tt0 -157.2 154.38 29.14 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 123.475 1.607 . . . . 0.0 107.203 -170.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.74 127.57 44.71 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.293 -1.776 . . . . 0.0 108.367 174.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -82.97 145.11 29.53 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.831 175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.67 -111.71 0.04 OUTLIER Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.1 -0.5 . . . . 0.0 113.259 -177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt -100.32 127.12 46.7 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.745 HD22 ' HB1' ' B' ' 59' ' ' ALA . 0.2 OUTLIER -98.88 115.48 28.94 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 -171.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.16 132.25 44.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' H ' ' HG2' ' A' ' 17' ' ' GLN . . . -57.09 137.61 55.57 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 123.571 1.653 . . . . 0.0 111.21 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.554 HG23 ' H ' ' B' ' 58' ' ' ARG . 3.4 t -131.83 -141.72 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 175.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.58 ' H ' ' HB3' ' B' ' 56' ' ' LYS . 0.0 OUTLIER -110.5 124.51 51.93 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 119.944 -1.722 . . . . 0.0 114.822 -151.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' B' ' 55' ' ' ILE . 1.5 p90 -120.64 155.95 32.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.664 -1.607 . . . . 0.0 110.985 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.778 ' HD3' ' HB2' ' A' ' 9' ' ' ALA . 6.4 mtmt -128.11 172.77 10.67 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 112.713 -2.039 . . . . 0.0 106.915 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.1 p -142.7 127.51 18.22 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.099 -1.0 . . . . 0.0 109.849 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -113.14 132.92 55.27 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 92.5 t -109.24 124.35 65.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 112.853 -1.976 . . . . 0.0 107.085 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.7 t -89.82 144.55 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 3' ' ' PRO . . . -121.74 148.0 45.19 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.021 1.391 . . . . 0.0 112.017 176.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.2 18.82 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.086 -1.87 . . . . 0.0 109.722 165.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 m -128.79 114.59 16.75 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 123.285 1.517 . . . . 0.0 109.408 -172.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.4 146.46 33.03 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 112.268 -2.242 . . . . 0.0 105.085 175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -129.66 134.75 47.85 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.002 -1.686 . . . . 0.0 107.538 -170.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.56 ' CD1' ' HG3' ' B' ' 46' ' ' GLN . 7.3 m-85 -128.75 130.32 46.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 -175.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.635 HD11 HD13 ' B' ' 19' ' ' ILE . 7.0 mt -129.34 142.91 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 121.697 0.761 . . . . 0.0 109.007 -173.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HD3' ' NE2' ' A' ' 66' ' ' HIS . 2.5 ttpt -106.83 142.28 36.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 124.332 2.015 . . . . 0.0 105.753 165.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG11 ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -146.77 145.83 19.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 111.354 -2.657 . . . . 0.0 105.807 -171.062 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.402 ' HB3' HG21 ' B' ' 41' ' ' VAL . 29.7 ptt180 -104.56 102.92 12.52 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 102.079 -3.304 . . . . 0.0 102.079 -176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.35 164.44 11.3 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-N 111.365 -2.652 . . . . 0.0 109.234 134.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.58 170.74 0.13 Allowed Glycine 0 CA--C 1.554 2.525 0 N-CA-C 115.388 0.915 . . . . 0.0 115.388 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 p30 -34.07 -29.33 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.797 0 N-CA-C 120.816 3.636 . . . . 0.0 120.816 171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -81.3 -36.89 29.26 Favored 'General case' 0 CA--C 1.576 1.97 0 C-N-CA 125.434 1.494 . . . . 0.0 113.605 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.15 157.79 35.53 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 123.357 1.551 . . . . 0.0 109.596 -174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -157.71 127.32 6.0 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.73 ' SD ' HD13 ' B' ' 27' ' ' LEU . 2.8 mtm -109.35 149.95 28.73 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 123.716 1.722 . . . . 0.0 111.634 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.473 ' HB2' ' CB ' ' A' ' 86' ' ' GLN . 5.7 m170 -106.23 154.11 21.19 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 112.34 -2.209 . . . . 0.0 108.536 163.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.896 HD21 HG21 ' B' ' 23' ' ' VAL . 0.2 OUTLIER -136.92 150.16 48.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.453 -2.158 . . . . 0.0 109.206 -177.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.52 117.63 10.07 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.888 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.554 HG23 HD23 ' A' ' 67' ' ' LEU . 77.8 t -128.73 124.13 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 -176.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -83.29 135.49 34.73 Favored 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.218 167.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -122.08 143.83 49.28 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.234 169.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.9 t -109.56 -80.54 0.58 Allowed 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 114.094 -1.412 . . . . 0.0 108.119 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 124.16 68.76 Favored Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 123.482 0.713 . . . . 0.0 110.081 -174.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.05 164.96 30.61 Favored 'Trans proline' 0 CA--C 1.561 1.873 0 C-N-CA 122.796 2.331 . . . . 0.0 112.629 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.82 -8.73 68.23 Favored Glycine 0 CA--C 1.55 2.234 0 N-CA-C 117.658 1.823 . . . . 0.0 117.658 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -124.86 105.96 9.65 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.491 ' O ' HD22 ' A' ' 80' ' ' LEU . 14.9 t30 -57.54 -45.69 84.78 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 116.764 -1.588 . . . . 0.0 112.429 166.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -20.97 6.69 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 173.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.37 -13.25 61.84 Favored 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 118.447 2.758 . . . . 0.0 118.447 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 77' ' ' ASN . 0.4 OUTLIER -58.8 120.99 10.0 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 124.005 0.922 . . . . 0.0 109.173 168.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.8 t -125.0 131.17 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.651 HD11 ' HD1' ' A' ' 85' ' ' TYR . 16.4 tp -64.33 112.61 3.15 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.306 165.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.4 p -111.14 -27.96 8.5 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 172.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -143.79 167.4 26.72 Favored Glycine 0 CA--C 1.547 2.07 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 172.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.651 ' HD1' HD11 ' A' ' 82' ' ' LEU . 4.6 p90 -172.84 126.89 0.48 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 119.536 -2.155 . . . . 0.0 105.592 -170.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -106.8 161.74 14.41 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 124.057 1.884 . . . . 0.0 108.45 177.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.39 -168.24 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.566 0 CA-C-N 112.538 -2.119 . . . . 0.0 111.87 -166.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -38.25 4.15 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.878 1 N-CA-C 122.719 4.34 . . . . 0.0 122.719 163.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.9 140.49 58.29 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 168.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -61.3 170.15 1.87 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 113.479 -1.691 . . . . 0.0 113.039 -168.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.596 ' HD2' HG11 ' B' ' 41' ' ' VAL . 8.6 tttm -54.68 -28.67 49.18 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 163.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.54 -28.06 42.81 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 117.769 2.507 . . . . 0.0 117.769 166.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -56.08 112.33 1.18 Allowed 'General case' 0 C--N 1.36 1.022 0 CA-C-N 118.993 0.815 . . . . 0.0 110.313 169.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 96' ' ' THR . 6.6 tt0 -80.62 134.2 35.86 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 54' ' ' TYR . 1.0 OUTLIER -81.11 102.09 10.04 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -178.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 94' ' ' GLU . 1.8 t -139.85 80.94 1.8 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -164.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 40.19 31.41 0.33 Allowed Glycine 0 CA--C 1.569 3.437 0 N-CA-C 118.752 2.261 . . . . 0.0 118.752 -172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.255 0.0 OUTLIER . . . . . 0 CA--C 1.568 1.657 0 C-N-CA 126.62 1.968 . . . . 0.0 109.504 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 12.7 tt -95.9 136.17 22.39 Favored Pre-proline 0 CA--C 1.568 1.66 0 C-N-CA 124.459 1.104 . . . . 0.0 108.036 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -66.47 158.01 57.63 Favored 'Trans proline' 0 CA--C 1.559 1.767 0 C-N-CA 121.787 1.658 . . . . 0.0 111.676 165.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.03 175.08 2.28 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-O 122.566 1.092 . . . . 0.0 113.517 166.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 154.68 7.08 Favored Glycine 0 N--CA 1.467 0.72 0 CA-C-O 123.912 1.84 . . . . 0.0 109.223 -165.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mp -69.76 146.46 51.45 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 111.992 -2.104 . . . . 0.0 112.078 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -174.62 0.34 Allowed 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 121.824 0.821 . . . . 0.0 111.533 176.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.76 140.83 58.18 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 122.616 1.198 . . . . 0.0 112.27 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' B' ' 43' ' ' TYR . . . -84.63 107.72 16.99 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 112.636 -2.074 . . . . 0.0 110.759 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 42' ' ' GLN . 20.8 mmtp -92.87 121.97 64.79 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-O 115.518 -2.182 . . . . 0.0 109.353 178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.06 6.37 0.5 Allowed 'Trans proline' 0 C--N 1.362 1.271 0 N-CA-C 121.1 3.461 . . . . 0.0 121.1 -170.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . 150.26 74.81 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.255 1.822 . . . . 0.0 106.745 176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' THR . . . . . 0.77 ' H ' HD12 ' B' ' 16' ' ' ILE . 0.1 OUTLIER -68.27 159.03 82.61 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 172.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' B' ' 13' ' ' THR . 59.5 Cg_endo -58.01 -36.03 98.33 Favored 'Trans proline' 0 CA--C 1.57 2.308 0 C-N-CA 121.684 1.589 . . . . 0.0 115.346 167.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -56.92 -49.44 75.61 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 163.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.77 HD12 ' H ' ' B' ' 13' ' ' THR . 28.4 mt -49.82 -50.78 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-N 120.763 1.619 . . . . 0.0 113.316 173.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . 0.481 ' CA ' ' HB2' ' B' ' 40' ' ' ALA . 0.4 OUTLIER -64.96 -40.85 95.63 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.666 0.604 . . . . 0.0 112.455 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -61.48 -39.31 90.48 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 169.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.635 HD13 HD11 ' A' ' 55' ' ' ILE . 16.7 mt -63.58 -58.65 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 CA-C-O 117.432 -1.27 . . . . 0.0 109.438 175.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.522 ' CG2' HG11 ' A' ' 57' ' ' VAL . 1.4 p -53.16 -41.36 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 171.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -58.28 -52.17 66.71 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 119.928 1.24 . . . . 0.0 112.398 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -61.62 -30.84 70.96 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 169.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.896 HG21 HD21 ' A' ' 67' ' ' LEU . 13.7 t -93.57 -13.46 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.59 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.05 178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 21.5 ttpt -49.94 -55.32 24.8 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 122.091 2.223 . . . . 0.0 113.825 169.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -62.16 -40.08 44.24 Favored 'Trans proline' 0 C--N 1.381 2.26 0 CA-C-N 123.737 2.37 . . . . 0.0 115.522 173.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.53 -38.68 81.06 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 124.959 1.303 . . . . 0.0 114.444 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.73 HD13 ' SD ' ' A' ' 65' ' ' MET . 0.5 OUTLIER -59.22 -47.84 83.84 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.198 0.999 . . . . 0.0 112.891 168.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.73 -37.5 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -64.2 -44.45 91.92 Favored 'General case' 0 CA--C 1.562 1.429 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 168.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -41.84 70.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 30.1 m -83.4 -8.91 59.31 Favored 'General case' 0 CA--C 1.577 1.995 0 CA-C-O 117.709 -1.139 . . . . 0.0 113.952 171.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASN . . . . . . . . . . . . . 54.3 t30 53.7 21.0 2.43 Favored 'General case' 0 CA--C 1.591 2.526 0 CA-C-N 121.554 1.979 . . . . 0.0 115.861 -166.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.26 149.95 38.38 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 122.431 1.11 . . . . 0.0 108.459 -172.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.73 126.35 49.81 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -108.52 147.27 31.98 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -65.87 -114.53 0.01 OUTLIER Glycine 0 CA--C 1.544 1.888 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.949 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' LYS . . . . . . . . . . . . . 1.2 tptp -103.81 127.59 51.29 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.487 HD21 ' HE1' ' A' ' 65' ' ' MET . 29.4 mt -101.87 115.34 30.31 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.61 145.78 38.58 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.481 ' HB2' ' CA ' ' B' ' 17' ' ' GLN . . . -56.3 140.19 45.81 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 123.443 1.592 . . . . 0.0 113.804 171.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.596 HG11 ' HD2' ' A' ' 91' ' ' LYS . 10.4 t -138.56 -146.65 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 111.017 -2.81 . . . . 0.0 104.432 173.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.511 ' H ' HG12 ' B' ' 41' ' ' VAL 0.286 12.8 pt20 -89.73 123.59 33.87 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 120.106 -1.621 . . . . 0.0 111.425 -162.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TYR . . . . . 0.685 ' CD1' HD11 ' B' ' 16' ' ' ILE . 0.1 OUTLIER -107.79 156.73 18.81 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 110.242 174.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -127.72 154.97 44.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 123.586 1.66 . . . . 0.0 108.491 167.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.11 161.5 14.1 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 113.782 -1.554 . . . . 0.0 108.16 177.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLN . . . . . 0.56 ' HG3' ' CD1' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -135.3 135.08 40.53 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 -174.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.96 118.43 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . . . . . . . . . 8.0 p -84.74 151.12 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.396 162.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ALA . . . . . . . . . . . . . . . -127.0 142.58 51.51 Favored 'General case' 0 CA--C 1.559 1.296 0 CA-C-O 122.252 1.025 . . . . 0.0 110.993 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . -123.08 151.5 16.86 Favored Glycine 0 N--CA 1.483 1.771 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 166.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 1.4 m -124.09 110.94 15.35 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.476 1.138 . . . . 0.0 108.532 -172.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.2 156.39 16.87 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 161.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -129.3 145.31 51.39 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 -175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' TYR . . . . . 0.435 ' HB3' HD22 ' B' ' 95' ' ' LEU . 15.2 m-85 -125.54 117.8 24.39 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 101.799 -3.408 . . . . 0.0 101.799 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.823 HD12 HG21 ' A' ' 19' ' ' ILE . 88.0 mt -121.82 146.51 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 CA-C-N 120.782 1.628 . . . . 0.0 110.251 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 42' ' ' GLN . 15.0 ttpt -114.33 143.82 44.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 123.723 1.725 . . . . 0.0 109.019 158.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . 0.6 HG21 HG11 ' A' ' 20' ' ' VAL . 12.5 p -162.6 117.29 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 112.464 -2.153 . . . . 0.0 107.435 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ARG . . . . . 0.554 ' H ' HG23 ' A' ' 41' ' ' VAL . 3.7 ptt180 -81.14 99.83 8.74 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 120.83 -1.169 . . . . 0.0 112.317 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' A' ' 38' ' ' LEU . . . -122.54 87.98 2.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.249 -2.251 . . . . 0.0 105.351 166.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' B' ' 63' ' ' LYS . . . -132.81 168.62 22.79 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 160.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -59.81 -56.72 18.3 Favored 'General case' 0 CA--C 1.572 1.808 0 O-C-N 121.86 -0.788 . . . . 0.0 111.416 161.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -116.75 18.02 15.0 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.476 1.658 . . . . 0.0 115.476 161.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . 0.418 ' HB2' ' HA3' ' B' ' 60' ' ' GLY . 0.6 OUTLIER -122.32 174.18 7.16 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.785 1.279 . . . . 0.0 111.516 -163.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' B' ' 58' ' ' ARG . 2.6 m-85 -125.18 133.56 52.73 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -173.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' MET . . . . . 0.546 ' SD ' HD13 ' A' ' 27' ' ' LEU . 1.2 ttm -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.89 -1.131 . . . . 0.0 107.978 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' HIS . . . . . 0.519 ' CD2' HD23 ' B' ' 95' ' ' LEU . 0.0 OUTLIER -136.46 114.75 11.66 Favored 'General case' 0 C--O 1.209 -1.067 0 O-C-N 120.238 -1.539 . . . . 0.0 111.601 175.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.715 HD11 HG11 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -129.45 141.86 50.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.71 140.23 29.78 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-N 114.141 -1.39 . . . . 0.0 112.681 169.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 19' ' ' ILE . 69.0 t -126.6 120.11 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -82.72 133.71 35.15 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.775 0.798 . . . . 0.0 111.146 167.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -123.42 147.28 47.28 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.583 -1.19 . . . . 0.0 110.517 170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 20.1 m -86.9 -91.61 0.1 Allowed 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . . . . . . . . . 77.8 mt -94.51 138.4 22.36 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.921 0.888 . . . . 0.0 110.59 -174.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.46 163.77 35.42 Favored 'Trans proline' 0 CA--C 1.562 1.905 0 C-N-CA 122.755 2.303 . . . . 0.0 112.743 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.98 11.17 85.65 Favored Glycine 0 CA--C 1.554 2.527 0 N-CA-C 117.993 1.957 . . . . 0.0 117.993 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -129.74 112.45 13.65 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -63.5 -41.28 98.54 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -65.41 -20.8 66.53 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.44 -22.6 66.32 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 118.168 2.655 . . . . 0.0 118.168 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.551 HD23 ' CD1' ' A' ' 19' ' ' ILE . 7.5 mp -80.67 111.13 16.81 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.404 ' C ' HG13 ' B' ' 69' ' ' VAL . 98.9 t -122.24 123.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -173.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' B' ' 85' ' ' TYR . 15.8 tp -70.89 113.14 7.65 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.079 166.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.43 -20.19 13.8 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 172.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -154.37 141.12 7.95 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' TYR . . . . . 0.474 ' HB3' HD11 ' B' ' 82' ' ' LEU . 25.1 p90 -145.13 155.59 43.4 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 123.526 1.631 . . . . 0.0 110.663 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -128.48 156.05 43.85 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.691 -2.049 . . . . 0.0 105.863 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.65 -169.71 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 112.449 -2.16 . . . . 0.0 109.003 -172.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -24.35 -8.86 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.832 1 N-CA-C 124.872 5.138 . . . . 0.0 124.872 165.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LYS . . . . . 0.554 ' HD2' ' HB2' ' B' ' 93' ' ' ASP . 0.0 OUTLIER -62.06 146.55 50.0 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 166.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -77.79 -176.86 4.6 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 112.555 -2.111 . . . . 0.0 111.271 -170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.83 -19.51 4.49 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 119.384 3.105 . . . . 0.0 119.384 166.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -55.97 -31.55 63.09 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 165.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ASP . . . . . 0.554 ' HB2' ' HD2' ' B' ' 89' ' ' LYS . 2.3 t0 -74.71 103.87 5.15 Favored 'General case' 0 C--N 1.361 1.101 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' GLU . . . . . 0.422 ' O ' HG23 ' B' ' 96' ' ' THR . 0.0 OUTLIER -85.36 140.56 30.68 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -178.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' B' ' 66' ' ' HIS . 0.0 OUTLIER -83.89 97.09 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.978 -177.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' THR . . . . . 0.422 HG23 ' O ' ' B' ' 94' ' ' GLU . 1.3 p -127.78 118.87 24.53 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 -161.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 46.19 32.7 5.14 Favored Glycine 0 CA--C 1.562 3.022 0 N-CA-C 117.898 1.919 . . . . 0.0 117.898 -169.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--O 1.242 0.684 1 N-CA-C 99.697 -4.186 . . . . 0.0 99.697 -160.833 . . . . . . . . 1 1 . 1 stop_ save_